Separate the questions
A disciplined review avoids treating every rule that affects a benefit plan as the same kind of regulation.
- What conduct, entity, transaction, or professional license does the state rule govern?
- Does the rule depend on the existence of an ERISA plan, or does it operate in transactions involving none?
- Who makes the challenged decision: the plan sponsor, the intermediary, the pharmacy, or another actor?
- Does the rule alter substantive coverage, regulate an intermediary’s conduct, or affect price only indirectly?
- What remedy remains when federal preemption removes the state pathway?
Follow doctrine and market structure together
A rule can be framed as benefit administration while operating through pharmacy contracts, network terms, reimbursement, and affiliated dispensing channels. Legal analysis benefits from testing that characterization against the actual transaction and the entity exercising control.
Use current posture, not labels
Complaints, preliminary rulings, merits decisions, settlements, and consent orders carry different weight. The court tracker and analysis archive identify the posture and source date so readers can distinguish an allegation from a holding and a negotiated restriction from precedent.